Marc Hasenfuss Editor-at-large

Investment company Remgro has enjoyed huge success in "supersizing" its key investments. Think Rothmans (merged into British American Tobacco) and Mediclinic (now a global private hospital business with a primary listing in London).

Liquor group Distell, though, has been relatively slow in its expansionary efforts (at least compared with the old SABMiller) — though it has built a formidable cider presence in the past 25 years. Remgro, following the dismantling of Capevin, will soon be large and in charge at Distell, heightening expectations of inspired deal making on the global stage.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, Morningstar financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00.